Gilead has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance. In her new role, she will join the company’s senior leadership team and report to chairman and CEO Daniel O’Day.
During her 14 years at Gilead, Wettan has held a variety of increasingly senior leadership roles. She was most recently Senior Vice President, leading the Global Legal Business Partners team. Prior to that, she led the Litigation and Government Investigations and the Corporate Governance and Strategic Transactions teams. She is currently Chair of the Board of the Gilead Foundation.
Wettan has provided instrumental support in a variety of drug launches, including the recent launch of the breakthrough HIV prevention medicine lenacapavir.
Prior to joining Gilead, Wettan was an attorney at Simpson Thacher & Bartlett.
Daniel O’Day, Gilead CEO, said: “Keeley is an accomplished executive who brings deep legal expertise, and who leads with integrity, passion and commitment to the people and communities we serve.
“During her 14-year career with Gilead, Keeley has helped to drive some of our most important progress from the launch of groundbreaking new medicines to pioneering access agreements.”